
RETATRUTIDE
TRIPLE RECEPTOR AGONIST
✓ 99.142% HPLC · Janoshik
A next-generation peptide targeting GLP-1, GIP, and glucagon receptors, studied in metabolic and glycemic research.
RESEARCH FOCUS
- Studied in metabolic and weight-regulation research
- Investigated for effects on glycemic control
- Examined for cardiometabolic markers in studies
- Researched for roles in appetite regulation






